Menopause (New York, N.Y.)

Weight loss treatments and sexual function in middle-aged women: possible role of GLP-1 medicines

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

GLP-1 receptor agonists have emerged as highly effective treatments for obesity.

  • Sexual health is an important aspect of women's overall well-being, particularly during midlife.
  • The menopause transition and obesity can negatively impact female sexual function.
  • The effects of GLP-1-based therapies on female sexual health are not well understood.
  • This review highlights the connections between obesity, midlife, and female sexual health.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Funding

Competing interests

Financial disclosures/Conflicts of interest: M.D.H.A. has served as a consultant for Novo Nordisk, Hoffman-La Roche, and Verge Genomics. Dr. Hurtado Andrade receives research funding from the National Institute of Health (K12-AR084222), the Mayo Clinic Center for Women’s Health Research, Eli Lilly, Endogenex, and Phenomix Sciences. C.L.S. is an advisor for Bayer Pharmaceutics. S.S.F. is a consultant for Era Women’s Health Platform, delivers CME lectures for PriMed, AiCME, MedAll, and Medscape, and serves on the scientific advisory board for Weight Watchers. The other authors have nothing to disclose.
PubMed

Related papers

Mar '26
GLP-1 receptor drugs and sexual function in women and men: current findings and the need for more research
top 20% journal
journal article
Apr '25
Real-world use, benefits, and side effects of new weight-loss treatments based on GLP-1 receptor activators
top 5% journal
cited by 98 papers
journal article
Apr '26
How GLP-1 receptor drugs and immune checkpoint inhibitors may interact: a review of their mechanisms and clinical effects
top 20% journal
journal article
Dec '25
Sexual problems linked to weight-loss drugs beyond their effects on metabolism
top 20% journal
journal article
Jun '25
Possible Links Between GLP-1 Drugs and Breast Cancer Risks and Safety
top 20% journal
cited by 2 papers
journal article
Feb '26
GLP-1 Drugs for Weight Loss in Older Women: Losing Fat While Keeping Muscle
top 10% journal
cited by 2 papers
journal article
Jan '26
Mental health results of obesity treatments with GLP-1 drugs compared to other obesity treatments
top 10% journal
cited by 3 papers
journal article
Oct '25
GLP-1 receptor drugs added to weight loss surgery for better weight and metabolism results: a review and analysis
top 30% journal
systematic review
Dec '25
How Weight-Loss Drugs Affect Sexual Desire and Why This Is Often Overlooked
top 20% journal
journal article

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #48
Stop the drug, regain the weight: pooled data puts the average rebound at 7%
2 days ago7 studies
issue #47
The brain region that explains why blocking and activating the same receptor both cause weight loss
1 week ago7 studies
issue #46
GLP-1 drugs linked to lower depression and bipolar disorder risk in large genetic study
2 weeks ago7 studies
issue #45
Stopping GLP-1 drugs linked to higher depression and anxiety risk in type 2 diabetes patients
3 weeks ago7 studies
issue #44
Tirzepatide cut all-cause mortality by more than half compared to semaglutide in a 47,000-patient study
4 weeks ago7 studies
issue #43
Semaglutide linked to 21% lower psychiatric hospitalization risk in bipolar disorder patients
5 weeks ago7 studies
issue #42
Tirzepatide users lost 14.7% of body weight vs. 10.8% with semaglutide — but Black and Hispanic patients were overrepresented in the lowest-response group
6 weeks ago8 studies
issue #41
New obesity drug survodutide cut weight by 13% vs 5.4% for placebo in 725 patients
7 weeks ago7 studies
issue #40
GLP-1 users had 3x higher risk of aspiration pneumonia after stroke surgery
8 weeks ago7 studies
issue #39
Semaglutide linked to reduced cigarette craving in 24 smokers
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief